|
INVESTIGATORS |
AGENCY |
YEAR |
|
|
||
|
|
|
|
|
Ken Dewar |
Genome
Large-scale
project: Regulatory Genetics – High throughput screening of gene
targets related to common genetic diseases. |
2001 – 2005 |
|
|
|
|
|
|
Canadian Foundation for
Innovation (Co-Investigator) Expansion of Genomics and
Proteomics Infrastructure in |
2002 – 2006 |
|
|
|
|
|
William Foulkes |
Breast cancer in three
dimensions: revealing telomere dysfunction in breast cancer |
2004 – 2005 |
|
|
|
|
|
|
The Cancer Research
Society (PI) Molecular mechanisms that
underlie exon deletions in hereditary colorectal cancer. |
2003 – 2005 |
|
|
|
|
|
|
CBCRI,
IDEA grant (PI) Characterisation
and response to treatment of BRCA1 and BRCA2 breast cell lines. |
2003 – 2004 |
|
|
|
|
|
|
CBCRI,
IDEA grant (PI) Characterisation
and response to treatment of BRCA1 and BRCA2 breast cell lines. |
2003 – 2004 |
|
|
|
|
|
|
US Army (PI) Identifying early events in
BRCA2-related breast cancer using isogenic cell lines. |
2003 – 2004 |
|
|
|
|
|
|
CBCRI
(Co-Investigator) Steven N, Principal Investigator Risk
factor analysis of hereditary breast and ovarian cancer |
2004 – 2009 |
|
|
|
|
|
|
CIHR (Co-Investigator)
Jass J. Principal Investigator Serrated polyps and
colorectal cancer: a correlative morphological and molecular study. |
2003 – 2006 |
|
|
|
|
|
|
The Cancer Research
Society (Co-Investigator) Al Moustafa A-E,
Principal Investigator Role of D-type cyclins in
neoplastic transformation of human epithelial cells induced by E6/E7/ErbB-2
cooperation. |
2003 – 2005 |
|
|
|
|
|
|
CIHR (Co-Investigator) Batista R, Principal Investigator Programme de recherche en appui aux politiques de santé en génétique dans un souci de qualité, d’efficience et de
bien-être social. |
2003 – 2007 |
|
|
|
|
|
Brian Gilfix |
Gustuv Levinschi
Foundation Award (Co-applicant) Modernization of
Thrombophilia Testing |
2004 |
|
|
|
|
|
Thomas Hudson |
Genome Technology Consortium: Development of a production system
for high-throughput genotyping using DNA chips |
2002 – 2004 |
|
|
|
|
|
|
Canadian Foundation for Innovation (Principal Investigator) Expansion of genomics and proteomics infrastructure in
|
2002 – 2006 |
|
|
|
|
|
|
Genome Canada/Genome
|
2002 – 2005 |
|
|
|
|
|
|
Networks
of Centres of Excellence (co-PI) Nadon R., Principal Investigator CGDN Microarray Analysis
Core Facility |
2003 – 2005 |
|
|
|
|
|
|
Canadian Institutes of Health
Research Fortin P, Principal Investigator Clinical Investigations
Genetic and Environmental Factors in Systemic Lupus Erythematosus. Focus on chromosome 1, apoptosis, and the
environment. |
2003 – 2008 |
|
|
|
|
|
|
Canadian Institute of
Health Research (Operating Grant) Mes-Masson A-M, Principal Investigator Selection and Validation of Target Genes
Implicated in the Clinical
and
Biological Features of Ovarian Cancer |
2002 – 2005 |
|
|
|
|
|
|
Juvenile Diabetes
Foundation International Polychronakos C, Principal Investigator A function-driven, large
scale approach to the search for type 1 diabetes susceptibility genes. |
2001
– 2006 |
|
|
|
|
|
|
Genome Canada/Genome
|
2001 – 2005 |
|
|
|
|
|
|
Genome
Canada/Genome Expertise
Centre: The |
2001 – 2005 |
|
|
|
|
|
|
Genome Canada/Genome
|
2001 – 2005 |
|
|
|
|
|
|
Canadian Genetic Analysis in Canadian Populations. |
2001 – 2006 |
|
|
|
|
|
|
Valorisation-Recherche
Québec Mes-Masson A-M, Principal Investigator
(Volet Recherche-soutien aux projets
structurantes) Plateformes structurantes du réseau cancer
du FRSQ: modélisation, services d’analyses et banques de tissus et de
données |
2002 – 2006 |
|
|
|
|
|
|
Burroughs
Wellcome Fund (Clinical Scientist Award in Translational Research) (PI) Genomic approaches to identify
genes predisposing to asthma |
2002
– 2007 |
|
|
|
|
|
|
Canadian
Institutes of Health Research Gaudet G, Principal Investigator Ecogene-21: An alliance for research in community
genetics Community Alliances for
Health Research |
2001
– 2006 |
|
|
|
|
|
|
Networks of Centres of
Excellence – Phase III (Genotyping Core Facility) (Principal
Investigator) Canadian
Genetic Diseases Network [CGDN]: |
1998 – 2005 |
|
|
|
|
|
Kenneth Morgan |
Networks of Centres of
Excellence (Investigator) Hayden MR,
Scientific Director Canadian Genetic Diseases
Network - Phase III: From genes to therapies |
1990 – 2005 |
|
|
|
|
|
|
Networks of Centres of
Excellence (Investigator) Gupta A, Program Leader in network Mathematics of Information
Technology and Complex Systems |
1999 – 2005 |
|
|
|
|
|
|
CIHR (Investigator) Schurr
E, Principal applicant Training centre in
integrative biology of infectious diseases and autoimmunity |
2003 – 2008 |
|
|
|
|
|
|
Genome Canada/Genome Quebec
(Investigator) Hudson TJ, Scientific coordinator Genome Quebec Genomic
Centre; Large-Scale Project:
Regulatory Genetics - high throughput screening of gene targets
related to common genetic diseases |
2001 – 2005 |
|
|
|
|
|
|
Genome Canada/Genome
Quebec (Investigator) Hudson TJ, Scientific coordinator Genome |
2001 – 2005 |
|
|
|
|
|
|
CIHR (Investigator) Rousseau F, Principal investigator Validation of genetic
markers of bone density and osteoporosis in a large
population-based sample |
2003 – 2006 |
|
|
|
|
|
|
NSERC Postdoctoral Fellowship to
Fabrice Larribe |
2004 – 2005 |
|
|
|
|
|
|
NSERC Undergraduate Student
Research Award to Daniel Yavin |
2003 – 2004 |
|
|
|
|
|
|
Canadian Genetic Diseases
Network (CGDN), Networks of Centres of Excellence CGDN Summer Studentship to
Daniel Yavin |
2003 |
|
|
|
|
|
David Rosenblatt |
March of Dimes (PI) Identification of genes
for cobalamin-dependent homocysteine remethylation. |
2001 - 2005 |
|
|
|
|
|
|
CIHR (Investigator) Inborn errors of cobalamin
and folate metabolism. |
2001 – 2005 |
|
|
|
|
|
Guy Rouleau |
CIHR Genetics and Molecular Investigation
of bipolar response to lithium |
2003 – 2008 |
|
|
|
|
|
|
CIHR Characterizing the gene
for peripheral neuropathy with agenesis of corpus callosum |
2002 – 2007 |
|
|
|
|
|
|
CIHR Molecular genetic
investigation of OPMD |
2002 – 2007 |
|
|
|
|
|
|
CIHR Identification of genes
predisposing to restless legs syndrome |
2003 – 2006 |
|
|
|
|
|
|
CIHR Searching for genes
predisposing to stroke |
2003 – 2006 |
|
|
|
|
|
|
MDA Identification of a new
gene for autosomal dominant familial amyotrophic lateral sclerosis |
2002 – 2004 |
|
|
|
|
|
|
FRSQ DNA and lymphoblastoid
cell bank for |
2003 – 2004 |
|
|
|
|
|
|
CIHR Genetic investigation of intracranial
aneurysm |
2001 – 2004 |
|
|
|
|
|
Patricia Tonin |
Fonds de la Recherche en Santé du Québec: Réseau cancérologie
(Investigator) Group Grant Banque de tissus et de données pour le cancer du sein et de
l’ovaire |
2000 – 2006 |
|
|
|
|
|
|
Canadian Foundation for
Innovation (Investigator) Host Institution: Université de Montéal Infrastructure -
Innovation Fund |
2000 – 2004 |
|
|
|
|
|
|
Valorisation-Recherche Québec (VRQ) (Investigator) Group Grant Banque de tissus et de données pour le cancer du sein et de
l’ovaire |
2002 - 2006 |
|
|
|
|
|
|
Canadian Foundation for
Innovation (Investigator) Expansion of genomics and
proteomics infrastructure in Québec Infrastructure - Innovation Fund |
2002 – 2006 |
|
|
|
|
|
|
Canadian Institutes of
Health Research (Investigator) Identification of tumor
suppressors in epithelial ovarian cancer |
2002 – 2005 |
|
|
|
|
|
|
Genome Integrative Genomics for
Women’s Health program (IGWH) |
2002 – 2005 |
|
|
|
|
|
|
Cancer Research Society,
Inc. (Investigator) Characterization of breast
cancer families of French Canadian descent: A genetic analysis of a founder population
in the search of a novel breast cancer susceptibility gene |
2002 – 2004 |
|
|
|
|
|
|
Cancer Research Society,
Inc. (Co-Pis) Strategic Grant A model for modulating
genetic and epigenetic events that influence the metastatic potential of
ovarian cancer |
2002
– 2005 |
|
|
|
|
|
|
New modalities for breast
cancer diagnosis and treatment |
2003 – 2006 |
Members | Report | Meetings
Publications | Funds | Financial
© 2005 Finestone Laboratory